FJX1 and head and neck squamous cell carcinoma: To determine whether HNSCC patients inherently harbour MAGED4B- and FJX1-specific T cells, we generated MAGED4B501-509/HLA-A2 tetramer using the HLA-A2 epitope we previously identified (39).